Atlas Trials

An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.

Clinical trial NCT02246868 · COMPLETED

Trial details

NCT number
NCT02246868
Sponsor
Bio Products Laboratory
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Haemophilia A
Start date
2001-09-01
Primary completion
2004-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.